Risk difference explained

The risk difference (RD), excess risk, or attributable risk[1] is the difference between the risk of an outcome in the exposed group and the unexposed group. It is computed as

Ie-Iu

, where

Ie

is the incidence in the exposed group, and

Iu

is the incidence in the unexposed group. If the risk of an outcome is increased by the exposure, the term absolute risk increase (ARI) is used, and computed as

Ie-Iu

. Equivalently, if the risk of an outcome is decreased by the exposure, the term absolute risk reduction (ARR) is used, and computed as

Iu-Ie

.[2] [3]

The inverse of the absolute risk reduction is the number needed to treat, and the inverse of the absolute risk increase is the number needed to harm.

Usage in reporting

It is recommended to use absolute measurements, such as risk difference, alongside the relative measurements, when presenting the results of randomized controlled trials.[4] Their utility can be illustrated by the following example of a hypothetical drug which reduces the risk of colon cancer from 1 case in 5000 to 1 case in 10,000 over one year. The relative risk reduction is 0.5 (50%), while the absolute risk reduction is 0.0001 (0.01%). The absolute risk reduction reflects the low probability of getting colon cancer in the first place, while reporting only relative risk reduction, would run into risk of readers exaggerating the effectiveness of the drug.[5]

Authors such as Ben Goldacre believe that the risk difference is best presented as a natural number - drug reduces 2 cases of colon cancer to 1 case if you treat 10,000 people. Natural numbers, which are used in the number needed to treat approach, are easily understood by non-experts.[6]

Inference

Risk difference can be estimated from a 2x2 contingency table:

 Group
Experimental (E)Control (C)
Events (E)EECE
Non-events (N)ENCN

The point estimate of the risk difference is

RD=

EE
EE+EN

-

CE
CE+CN

.

The sampling distribution of RD is approximately normal, with standard error

SE(RD)=\sqrt{

EEEN
(EE+EN)3

+

CECN
(CE+CN)3
}.

The

1-\alpha

confidence interval for the RD is then

CI1(RD)=RD\pmSE(RD)z\alpha,

where

z\alpha

is the standard score for the chosen level of significance

Bayesian interpretation

We could assume a disease noted by

D

, and no disease noted by

\negD

, exposure noted by

E

, and no exposure noted by

\negE

. The risk difference can be written as

RD=P(D\midE)-P(D\mid\negE).

Numerical examples

Risk increase

See also

Notes and References

  1. Book: Dictionary of Epidemiology. 2014 . Oxford University Press. 978-0-19-939006-9. Porta M. 6th. 14. 10.1093/acref/9780199976720.001.0001.
  2. Web site: Dictionary of Epidemiology - Oxford Reference. 2014. Oxford University Press . en. 10.1093/acref/9780199976720.001.0001. 9780199976720. 2018-05-09. Porta. Miquel.
  3. Book: J., Rothman, Kenneth. Epidemiology : an introduction. 2012. Oxford University Press. 9780199754557. 2nd. New York, NY. 66, 160, 167. 750986180.
  4. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. March 2010. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 340. c869. 10.1136/bmj.c869. 2844943. 20332511.
  5. Stegenga. Jacob. 2015. Measuring Effectiveness. Studies in History and Philosophy of Biological and Biomedical Sciences. 54. 62–71. 10.1016/j.shpsc.2015.06.003. 26199055.
  6. Book: Bad Science. Ben Goldacre. Fourth Estate. 2008. 978-0-00-724019-7. New York. 239–260.